INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $712 | -18.7% | 22,531 | +4.8% | 0.01% | -16.7% |
| Q2 2023 | $876 | +7.7% | 21,492 | -1.5% | 0.01% | +20.0% |
| Q1 2023 | $813 | +12.9% | 21,815 | +5.7% | 0.01% | 0.0% |
| Q4 2022 | $720 | -99.9% | 20,644 | -7.3% | 0.01% | -44.4% |
| Q3 2022 | $1,246,000 | +124.1% | 22,273 | +107.4% | 0.01% | +125.0% |
| Q2 2022 | $556,000 | -45.3% | 10,739 | -23.3% | 0.00% | -20.0% |
| Q1 2022 | $1,017,000 | -32.5% | 13,994 | +9.8% | 0.01% | -28.6% |
| Q4 2021 | $1,507,000 | +16.0% | 12,747 | +31.7% | 0.01% | 0.0% |
| Q3 2021 | $1,299,000 | +0.8% | 9,681 | +21.6% | 0.01% | 0.0% |
| Q2 2021 | $1,289,000 | +214.4% | 7,962 | +55.8% | 0.01% | +250.0% |
| Q1 2021 | $410,000 | +82.2% | 5,110 | +23.5% | 0.00% | +100.0% |
| Q4 2020 | $225,000 | – | 4,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |